STOCK TITAN

Maravai LifeSciences Announces September 2021 Investor Conference Schedule

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Maravai LifeSciences (NASDAQ: MRVI) will participate in two virtual investor conferences in September 2021. CEO Carl Hull is set to engage in a fireside chat at the Morgan Stanley Healthcare Conference on September 13 at 12:30 p.m. PT, followed by CFO Kevin Herde's presentation at the Baird Global Healthcare Conference on September 14 at 9:50 a.m. PT. Live webcasts will be accessible on the Maravai investor relations website, with archived versions available shortly after each event.

Positive
  • Participation in two significant healthcare conferences may enhance investor visibility.
  • CEOs and CFOs speaking engagements are likely to attract interest from potential investors.
Negative
  • None.

SAN DIEGO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of September.

On September 13, 2021, Carl Hull, Chief Executive Officer will participate in a fireside chat at the Morgan Stanley Healthcare Conference at 12:30 p.m. PT.

On September 14, 2021, Kevin Herde, Chief Financial Officer, will present at the Baird Global Healthcare Conference at 9:50 a.m. PT.

A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion of each event on the Maravai investor relations website.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

For more information about Maravai LifeSciences, visit www.maravai.com.


FAQ

What events is Maravai LifeSciences participating in during September 2021?

Maravai LifeSciences will participate in the Morgan Stanley Healthcare Conference on September 13 and the Baird Global Healthcare Conference on September 14, 2021.

Who will represent Maravai LifeSciences at the investor conferences?

CEO Carl Hull will participate in the Morgan Stanley Healthcare Conference, and CFO Kevin Herde will present at the Baird Global Healthcare Conference.

Where can I watch the presentations of Maravai LifeSciences?

The presentations will be available via live webcast on Maravai LifeSciences' investor relations website.

What is Maravai LifeSciences known for?

Maravai LifeSciences is a leading provider of life science reagents and services supporting drug therapies, diagnostics, and vaccine development.

Maravai Lifesciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

432.62M
119.86M
1.2%
102.45%
6.29%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO